Patents by Inventor Jonathan Paul Huggins

Jonathan Paul Huggins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for the treatment of damaged tissue
    Publication number: 20030199440
    Abstract: A pharmaceutical for use in damaged tissue, such as wound, treatment (e.g. healing) is described. The pharmaceutical comprising a composition which comprises: (a) a growth factor; and (b) an inhibitor agent; and optionally (c) a pharmaceutically acceptable carrier, diluent or excipient; wherein the inhibitor agent can inhibit the action of at least one specific adverse protein (e.g. a specific protease) that is upregulated in a damaged tissue, such as a wound, environment.
    Type: Application
    Filed: April 25, 2002
    Publication date: October 23, 2003
    Applicant: Pfizer Inc.
    Inventors: Kevin Neil Dack, Michael John Davies, Paul Vincent Fish, Jonathan Paul Huggins, Fraser Stuart McIntosh, Nicholas Laurence Occleston
  • Treatment of wounds
    Publication number: 20020065286
    Abstract: This invention relates to the use of cyclic guanosine 3′, 5′-monophosphate type five (cGMP PDE5) inhibitors (hereinafter PDE5 inhibitors), including in particular the compound sildenafil, for the treatment of chronic wounds of a non-diabetic origin including in particular chronic venous ulcers, chronic decubitus (pressure sores) and arterial ulcers; and acute wounds.
    Type: Application
    Filed: August 10, 2001
    Publication date: May 30, 2002
    Inventors: Michael John Davies, Jonathan Paul Huggins, Dinah Parums